NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Northwest Biotherapeutics Inc (OTCQB: NWBO)

 
NWBO Technical Analysis
1
As on 9th Jun 2023 NWBO STOCK Price closed @ 0.73 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NWBOSTOCK Price

Open 0.75 Change Price %
High 0.79 1 Day N/A N/A
Low 0.72 1 Week 0.00 0.00
Close 0.73 1 Month 0.00 0.00
Volume 2273400 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
OTCQB USA Most Active Stocks
BMIX 0.01 %
MOBQ 0.18 %
FNMA 0.45 %
ALPP 3.56 0.00%
ALPP 3.56 0.00%
SHMP 0.06 %
NWBO 0.73 %
VPLM 0.08 %
NLST 3.72 %
SRNA 2.78 14.88%
 
OTCQB USA Top Gainers Stocks
EWLUD 0.45 275.00%
HCAND 0.02 100.00%
PMMCF 0.34 55.56%
PMMCF 0.34 55.56%
TUMIF 0.09 50.00%
EXDI 0.82 38.98%
NVMDF 0.27 35.00%
NVMDF 0.27 35.00%
GYRRF 0.24 33.33%
QTRRF 0.10 25.00%
 
OTCQB USA Top Losers Stocks
ETST 0.03 -25.00%
ETST 0.03 -25.00%
FDMSF 0.03 -25.00%
EMPR 19.46 -20.73%
EMPR 19.46 -20.73%
IFNY 0.04 -20.00%
UBMRD 0.56 -15.15%
HARY 0.06 -14.29%
HARY 0.06 -14.29%
NPDCF 0.06 -14.29%
 
 
NWBO
Daily Charts
NWBO
Intraday Charts
Whats New @
Bazaartrend
NWBO
Free Analysis
 
NWBO Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
NWBO Forecast December 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
NWBO Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
NWBO Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
NWBO Other Details
Segment EQ
Market Capital 1012030400.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NWBO Address
NWBO
 
NWBO Latest News
 
Your Comments and Response on Northwest Biotherapeutics Inc
 
NWBO Business Profile
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L that is in Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland. Address: 4800 Montgomery Lane, Bethesda, MD, United States, 20814
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service